Selection for chloroquine-sensitive Plasmodium falciparum by wild Anopheles arabiensis in Southern Zambia

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Mharakurwa, Sungano ^a,b   Sialumano, Mavis ^a   Liu, Kun ^b   Scott, Alan ^b   Thuma, Philip ^a,b  

^a Malaria Institute at Macha   (Zambia)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHLOROQUINE; RESTRICTION ENDONUCLEASE;

ABDOMINAL INFECTION; ANOPHELES ARABIENSIS; ARTICLE; CODON; DRUG SENSITIVITY; GENOTYPE; HUMAN; MALARIA CONTROL; MALARIA FALCIPARUM; MICROSCOPY; MOSQUITO; MOUTH INFECTION; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PYRETHRUM; SALIVARY GLAND; SCREENING; SMEAR; WILD TYPE; ZAMBIA;

ANIMALS; ANOPHELES; ANTIMALARIALS; CHLOROQUINE; CROSS-SECTIONAL STUDIES; DNA, PROTOZOAN; GENOTYPE; MEMBRANE TRANSPORT PROTEINS; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTOZOAN PROTEINS; SELECTION, GENETIC; ZAMBIA;

EID: 84890325836     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-453     Document Type: Article

References (51)

1. Evolution of Plasmodium falciparum drug resistance: implications for the development and containment of artemisinin resistance. Mita T, Tanabe K, Jpn J Infect Dis 2012 65 465 475 10.7883/yoken.65.465 23183197
2. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Amaratunga C, Sreng S, Suon S, Phelps ES, Stepniewska K, Lim P, Zhou C, Mao S, Anderson JM, Lindegardh N, Jiang H, Song J, Su XZ, White NJ, Dondorp AM, Anderson TJ, Fay MP, Mu J, Duong S, Fairhurst RM, Lancet Infect Dis 2012 12 851 858 10.1016/S1473-3099(12)70181-0 22940027
3. Artemisinin resistance or artemisinin-based combination therapy resistance? Wongsrichanalai C, Lancet Infect Dis 2013 13 114 115 10.1016/S1473-3099(12)70349-3 23347632
4. Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study. Carrara VI, Lwin KM, Phyo AP, Ashley E, Wiladphaingern J, Sriprawat K, Rijken M, Boel M, McGready R, Proux S, Chu C, Singhasivanon P, White N, Nosten F, PLoS Med 2013 10 1001398 10.1371/journal.pmed.1001398 23472056
5. Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia. Satimai W, Sudathip P, Vijaykadga S, Khamsiriwatchara A, Sawang S, Potithavoranan T, Sangvichean A, Delacollette C, Singhasivanon P, Kaewkungwal J, Lawpoolsri S, Malar J 2012 11 300 10.1186/1475-2875-11-300 22929621
6. Artemisinin-resistant malaria: research challenges, opportunities, and public health implications. Fairhurst RM, Nayyar GM, Breman JG, Hallett R, Vennerstrom JL, Duong S, Ringwald P, Wellems TE, Plowe CV, Dondorp AM, Am J Trop Med Hyg 2012 87 231 241 10.4269/ajtmh.2012.12-0025 22855752
7. Resistance to artemisinin-based combination therapy. Breman JG, Lancet Infect Dis 2012 12 820 822 10.1016/S1473-3099(12)70226-8 22940026
8. Strategies for the prevention of antimalarial drug resistance: Rationale for combination chemotherapy for malaria. White NJ, Olliaro PL, Parasitol Today 1996 12 399 401 10.1016/0169-4758(96)10055-7 15275291
9. Monitoring and deterring drug-resistant malaria in the era of combination therapy. Laufer MK, Djimde AA, Plowe CV, Am J Trop Med Hyg 2007 77 160 169 18165489
10. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting. WHO MPAC, Secretariat, Malar J 2012 11 424 23253143
11. Drug resistant falciparum malaria: clinical consequences and strategies for prevention. Price RN, Nosten F, Drug Resist Updat 2001 4 187 196 10.1054/drup.2001.0195 11768332
12. WHO, WHO Briefing on Malaria Treatment Guidelines and Artemisinin Monotherapies Geneva: World Health Organization 2006
13. Focused Screening and Treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. falciparum, Pailin, Cambodia. Hoyer S, Nguon S, Kim S, Habib N, Khim N, Sum S, Christophel EM, Bjorge S, Thomson A, Kheng S, Chea N, Yok S, Top S, Ros S, Sophal U, Thompson MM, Mellor S, Ariey F, Witkowski B, Yeang C, Yeung S, Duong S, Newman RD, Menard D, PLoS One 2012 7 45797 10.1371/journal.pone.0045797 23049687
14. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar. Kyaw MP, Nyunt MH, Chit K, Aye MM, Aye KH, Aye MM, Lindegardh N, Tarning J, Imwong M, Jacob CG, Rasmussen C, Perin J, Ringwald P, Nyunt MM, PLoS One 2013 8 57689 10.1371/journal.pone.0057689 23520478
15. Temporal trends of molecular markers associated with artemether- lumefantrine tolerance/resistance in Bagamoyo district. Malmberg M, Ngasala B, Ferreira PE, Larsson E, Jovel I, Hjalmarsson A, Petzold M, Premji Z, Gil JP, Bjorkman A, Martensson A, Tanzania. Malar J 2013 12 103
16. Intensity of malaria transmission and the evolution of drug resistance. Hastings IM, Watkins WM, Acta Trop 2005 94 218 229 10.1016/j.actatropica.2005. 04.003 15847846
17. Increasing prevalence of wildtypes in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets. Alifrangis M, Lemnge MM, Ronn AM, Segeja MD, Magesa SM, Khalil IF, Bygbjerg IC, Am J Trop Med Hyg 2003 69 238 243 14628937
18. Association of house spraying with suppressed levels of drug resistance in Zimbabwe. Mharakurwa S, Mutambu SL, Mudyiradima R, Chimbadzwa T, Chandiwana SK, Day KP, Malar J 2004 3 35 10.1186/1475-2875-3-35 15491495
19. Effect of transmission reduction by insecticide-treated bednets (ITNs) on antimalarial drug resistance in western Kenya. Shah M, Kariuki S, Vanden Eng J, Blackstock AJ, Garner K, Gatei W, Gimnig JE, Lindblade K, Terlouw D, ter Kuile F, Hawley WA, Phillips-Howard P, Nahlen B, Walker E, Hamel MJ, Slutsker L, Shi YP, PLoS One 2011 6 26746 10.1371/journal.pone.0026746 22096496
20. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia. Hailemeskel E, Kassa M, Taddesse G, Mohammed H, Woyessa A, Tasew G, Sleshi M, Kebede A, Petros B, Acta Trop 2013 128 636 641 10.1016/j.actatropica.2013.09.010 24055717
21. Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal. Ndiaye M, Faye B, Tine R, Ndiaye JL, Lo A, Abiola A, Dieng Y, Ndiaye D, Hallett R, Alifrangis M, Gaye O, Am J Trop Med Hyg 2012 87 640 645 10.4269/ajtmh.2012. 11-0709 22927495
22. Changes in genotypes of Plasmodium falciparum human malaria parasite following withdrawal of chloroquine in Tiwi, Kenya. Mang'era CM, Mbai FN, Omedo IA, Mireji PO, Omar SA, Acta Trop 2012 123 202 207 10.1016/j.actatropica.2012. 05.007 22641431
23. Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Mita T, Kaneko A, Lum JK, Bwijo B, Takechi M, Zungu IL, Tsukahara T, Tanabe K, Kobayakawa T, Bjorkman A, Am J Trop Med Hyg 2003 68 413 415 12875289
24. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, Kazembe PN, Djimde AA, Kouriba B, Taylor TE, Plowe CV, J Infect Dis 2003 187 1870 1875 10.1086/375419 12792863
25. Evidence of increased chloroquine sensitivity in Thai isolates of Plasmodium falciparum. Thaithong S, Suebsaeng L, Rooney W, Beale GH, Trans R Soc Trop Med Hyg 1988 82 37 38 10.1016/0035-9203(88)90255-6 3051547
26. Analysis of genetic mutations associated with anti-malarial drug resistance in Plasmodium falciparum from the Democratic Republic of East Timor. de Almeida A, Arez AP, Cravo PV, do Rosario VE, Malar J 2009 8 59 10.1186/1475-2875-8-59 19358729
27. A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon. Frank M, Lehners N, Mayengue PI, Gabor J, Dal-Bianco M, Kombila DU, Ngoma GM, Supan C, Lell B, Ntoumi F, Grobusch MP, Dietz K, Kremsner PG, Malar J 2011 10 304 10.1186/1475-2875-10-304 22004584
28. Large differences in prevalence of Pfcrt and Pfmdr1 mutations between Mwanza, Tanzania and Iganga, Uganda-a reflection of differences in policies regarding withdrawal of chloroquine? Kamugisha E, Bujila I, Lahdo M, Pello-Esso S, Minde M, Kongola G, Naiwumbwe H, Kiwuwa S, Kaddumukasa M, Kironde F, Swedberg G, Acta Trop 2012 121 148 151 10.1016/j.actatropica.2011.11.004 22118982
29. Chloroquine resistance before and after its withdrawal in Kenya. Mwai L, Ochong E, Abdirahman A, Kiara SM, Ward S, Kokwaro G, Sasi P, Marsh K, Borrmann S, Mackinnon M, Nzila A, Malar J 2009 8 106 10.1186/1475-2875-8-106 19450282
30. Malaria antifolate resistance with contrasting Plasmodium falciparum dihydrofolate reductase (DHFR) polymorphisms in humans and Anopheles mosquitoes. Mharakurwa S, Kumwenda T, Mkulama MA, Musapa M, Chishimba S, Shiff CJ, Sullivan DJ, Thuma PE, Liu K, Agre P, Proc Natl Acad Sci USA 2011 108 18796 18801 10.1073/pnas.1116162108 22065788
31. A molecular marker for chloroquine-resistant falciparum malaria. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152
32. Molecular differentiation of colonized human malaria vectors by 28S ribosomal DNA polymorphisms. Kent RJ, West AJ, Norris DE, Am J Trop Med Hyg 2004 71 514 517 15516651
33. A simple Chelex protocol for DNA extraction from Anopheles spp. Musapa M, Kumwenda T, Mkulama M, Chishimba S, Norris DE, Thuma PE, Mharakurwa S, J Vis Exp 2013 71 doi: 10.3791/3281
34. Determination of genetic variation within Plasmodium falciparum by using enzymatically amplified DNA from filter paper disks impregnated with whole blood. Kain KC, Lanar DE, J Clin Microbiol 1991 29 1171 1174 1864936
35. Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Djimde A, Doumbo OK, Steketee RW, Plowe CV, Lancet 2001 358 890 891 10.1016/S0140-6736(01)06040-8 11567708
36. Monitoring chloroquine resistance using Plasmodium falciparum parasites isolated from wild mosquitoes in Tanzania. Temu EA, Kimani I, Tuno N, Kawada H, Minjas JN, Takagi M, Am J Trop Med Hyg 2006 75 1182 1187 17172390
37. Assessing the cost-benefit effect of a Plasmodium falciparum drug resistance mutation on parasite growth in vitro. Froberg G, Ferreira PE, Martensson A, Ali A, Bjorkman A, Gil JP, Antimicrob Agents Chemother 2013 57 887 892 10.1128/AAC.00950-12 23208719
38. Cytochrome b mutation Y268S conferring atovaquone resistance phenotype in malaria parasite results in reduced parasite bc1 catalytic turnover and protein expression. Fisher N, Abd Majid R, Antoine T, Al-Helal M, Warman AJ, Johnson DJ, Lawrenson AS, Ranson H, O'Neill PM, Ward SA, Biagini GA, J Biol Chem 2012 287 9731 9741 10.1074/jbc.M111.324319 22282497
39. Impaired fitness of drug-resistant malaria parasites: evidence and implication on drug-deployment policies. Babiker HA, Hastings IM, Swedberg G, Expert Rev Anti Infect Ther 2009 7 581 593 10.1586/eri.09.29 19485798
40. Fitness of drug-resistant malaria parasites. Walliker D, Hunt P, Babiker H, Acta Trop 2005 94 251 259 10.1016/j.actatropica.2005.04.005 15845348
41. PfCRT and its role in antimalarial drug resistance. Ecker A, Lehane AM, Clain J, Fidock DA, Trends Parasitol 2012 28 504 514 10.1016/j.pt.2012.08.002 23020971
42. Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites. Ord R, Alexander N, Dunyo S, Hallett R, Jawara M, Targett G, Drakeley CJ, Sutherland CJ, J Infect Dis 2007 196 1613 1619 10.1086/522154 18008244
43. An immune-responsive serpin, SRPN6, mediates mosquito defense against malaria parasites. Abraham EG, Pinto SB, Ghosh A, Vanlandingham DL, Budd A, Higgs S, Kafatos FC, Jacobs-Lorena M, Michel K, Proc Natl Acad Sci USA 2005 102 16327 16332 10.1073/pnas.0508335102 16260729
44. Efficiency of salivary gland invasion by malaria sporozoites is controlled by rapid sporozoite destruction in the mosquito haemocoel. Hillyer JF, Barreau C, Vernick KD, Int J Parasitol 2007 37 673 681 10.1016/j.ijpara. 2006.12.007 17275826
45. Midgut microbiota of the malaria mosquito vector Anopheles gambiae and interactions with Plasmodium falciparum infection. Boissiere A, Tchioffo MT, Bachar D, Abate L, Marie A, Nsango SE, Shahbazkia HR, Awono-Ambene PH, Levashina EA, Christen R, Morlais I, PLoS Pathog 2012 8 1002742 10.1371/journal.ppat. 1002742 22693451
46. Enterobacter-activated mosquito immune responses to Plasmodium involve activation of SRPN6 in Anopheles stephensi. Eappen AG, Smith RC, Jacobs-Lorena M, PLoS One 2013 8 62937 10.1371/journal.pone.0062937 23658788
47. Natural microbe-mediated refractoriness to Plasmodium infection in Anopheles gambiae. Cirimotich CM, Dong Y, Clayton AM, Sandiford SL, Souza-Neto JA, Mulenga M, Dimopoulos G, Science 2011 332 855 858 10.1126/science.1201618 21566196
48. Sulfadoxine-pyrimethamine impairs Plasmodium falciparum gametocyte infectivity and Anopheles mosquito survival. Kone A, van de Vegte-Bolmer M, Siebelink-Stoter R, van Gemert GJ, Dara A, Niangaly H, Luty A, Doumbo OK, Sauerwein R, Djimde AA, Int J Parasitol 2010 40 1221 1228 10.1016/j.ijpara.2010. 05.004 20515695
49. The efficacy of sulfadoxine-pyrimethamine alone and in combination with chloroquine for malaria treatment in rural Eastern Sudan: the interrelation between resistance, age and gametocytogenesis. A-Elbasit IE, Elbashir MI, Khalil IF, Alifrangis M, Giha HA, Trop Med Int Health 2006 11 604 612 10.1111/j.1365-3156.2006.01616.x 16640612
50. Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China. Liu DQ, Liu RJ, Ren DX, Gao DQ, Zhang CY, Qui CP, Cai XZ, Ling CF, Song AH, Tang X, Bull World Health Organ 1995 73 483 486 7554020
51. Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites. Laufer MK, Takala-Harrison S, Dzinjalamala FK, Stine OC, Taylor TE, Plowe CV, J Infect Dis 2010 202 801 808 10.1086/655659 20662717